Belief BioMed Inc. (BBM) is a pioneering biotech company focused on the research, development, manufacturing, and clinical application of gene therapy products. The company specializes in innovative gene therapies aimed at treating severe genetic and chronic diseases, utilizing advanced viral vector technology, particularly adeno-associated virus (AAV) vectors. BBM has developed a range of proprietary technologies, including a serum-free culture process for HEK293 cells and a full-scale chromatography purification process, which are essential for the efficient production of gene therapy drugs. The company has established a commercial production platform in China and is actively expanding its capabilities in various fields, such as novel AAV capsids, transgene expression cassette design, and clinical-grade vector manufacturing.

BBM's extensive research and development pipeline addresses significant unmet medical needs across multiple therapeutic areas, including hemophilia, Parkinson's disease, and neuromuscular disorders. Notably, BBM-H901, an AAV gene therapy for hemophilia B, has gained regulatory approvals and is recognized as a groundbreaking treatment in China. The therapy aims for long-term effectiveness through a single intravenous administration, significantly improving the quality of life for patients. BBM's commitment to innovation and safety in gene therapy positions it as a leader in the biotech industry, with several product candidates already in clinical studies or under regulatory review.

China

Founded in 2018, Belief BioMed is aiming to become a globally leading gene therapy company by being committed to providing innovative therapies with improved efficacy for monogenic disorder diseases, age-related degenerative diseases, and certain malignant diseases through its AAV vector technology from early discovery to commercialization. The R&D and production strengths of Belief BioMed have been recognized by top investment institutions and enterprises. Belief BioMed has offices, research centers and manufacturing facilities in Shanghai, Hong Kong, Beijing and Suzhou China and North Carolina US.

Cancer

Eye Diseases

Genetic Diseases

Hematologic Diseases

Metabolic Diseases

Musculoskeletal Diseases

Nervous System Diseases

Belief BioMed

Hemophilia

BBM-H901

Biologics

Gene Therapy

Belief BioMed Drug #1

Parkinson's disease

Belief BioMed Drug #2

Arthritis

Belief BioMed Drug #3

Belief BioMed Drug #4

Metabolic disorder

Belief BioMed Drug #5

Opthalmology

Belief BioMed Drug #6

Hereditary Muscle Disease

Belief BioMed Drug #7

Musculoskeletal Disease

Belief BioMed Drug #8

Lysosomal storage disorder

Belief BioMed Drug #9

Adeno-associated viral vector (AAV)

Antiviral Therapies

Therapeutic

Belief BioMed

Company Details